| Preferred Name |
Diffuse large B-cell lymphoma |
| ID |
http://www.orpha.net/ORDO/Orphanet_544 |
| alternative_term |
DLBCL |
| definition |
Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL; see this term) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common. |
| definition_citation |
Orphanet |
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=544 |
| has_age_of_onset |
Adult |
| has_inheritance |
Not applicable Multigenic/multifactorial |
| hasDbXref |
ICD-10:C83.3 UMLS:C0079744 MeSH:D016403 MedDRA:10012818 ICD-11:2A81 |
| label |
Diffuse large B-cell lymphoma |
| notation |
ORPHA:544 Clinical group |
| prefixIRI |
ORDO:Orphanet_544 |
| prefLabel |
Diffuse large B-cell lymphoma |
| present_in |
Slovakia AND has_annual_incidence_average_value : 3.259 AND has_annual_incidence_range : 1-9 / 100 000 Switzerland AND has_annual_incidence_average_value : 6.328 AND has_annual_incidence_range : 1-9 / 100 000 Spain AND has_annual_incidence_average_value : 4.78 AND has_annual_incidence_range : 1-9 / 100 000 Malta AND has_annual_incidence_average_value : 2.827 AND has_annual_incidence_range : 1-9 / 100 000 Netherlands AND has_annual_incidence_average_value : 6.478 AND has_annual_incidence_range : 1-9 / 100 000 Bulgaria AND has_annual_incidence_average_value : 1.229 AND has_annual_incidence_range : 1-9 / 100 000 Slovenia AND has_annual_incidence_average_value : 4.773 AND has_annual_incidence_range : 1-9 / 100 000 Germany AND has_annual_incidence_average_value : 4.586 AND has_annual_incidence_range : 1-9 / 100 000 France AND has_annual_incidence_average_value : 6.5 AND has_annual_incidence_range : 1-9 / 100 000 Estonia AND has_annual_incidence_average_value : 3.815 AND has_annual_incidence_range : 1-9 / 100 000 Italy AND has_annual_incidence_average_value : 6.47 AND has_annual_incidence_range : 1-9 / 100 000 Belgium AND has_annual_incidence_average_value : 5.51 AND has_annual_incidence_range : 1-9 / 100 000 Portugal AND has_annual_incidence_average_value : 2.635 AND has_annual_incidence_range : 1-9 / 100 000 Ireland AND has_annual_incidence_average_value : 3.458 AND has_annual_incidence_range : 1-9 / 100 000 Austria AND has_annual_incidence_average_value : 2.227 AND has_annual_incidence_range : 1-9 / 100 000 Latvia AND has_annual_incidence_average_value : 0.298 AND has_annual_incidence_range : 1-9 / 1 000 000 Lithuania AND has_annual_incidence_average_value : 2.984 AND has_annual_incidence_range : 1-9 / 100 000 Norway AND has_annual_incidence_average_value : 5.115 AND has_annual_incidence_range : 1-9 / 100 000 Finland AND has_annual_incidence_average_value : 1.244 AND has_annual_incidence_range : 1-9 / 100 000 Iceland AND has_annual_incidence_average_value : 4.559 AND has_annual_incidence_range : 1-9 / 100 000 Czech Republic AND has_annual_incidence_average_value : 3.304 AND has_annual_incidence_range : 1-9 / 100 000 Croatia AND has_annual_incidence_average_value : 0.765 AND has_annual_incidence_range : 1-9 / 1 000 000 Europe AND has_annual_incidence_average_value : 2.79 AND has_annual_incidence_range : 1-9 / 100 000 United Kingdom AND has_annual_incidence_average_value : 4.931 AND has_annual_incidence_range : 1-9 / 100 000 Poland AND has_annual_incidence_average_value : 1.673 AND has_annual_incidence_range : 1-9 / 100 000 Europe AND has_point_prevalence_average_value : 43.0 AND has_point_prevalence_range : 1-5 / 10 000 |
| subClassOf |